Abstract
Overexpression of human growth factor receptor 2 (HER2) is associated with poor outcomes in patients with gastric cancer (GC). However, its prognostic implications in surgically treated patients with GC is unknown.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
